New Publication Validates Triaging Tool for COVID Patients
Immunexpress detailed a study that validated the use of its SeptiCyte RAPID as a triaging tool for COVID patients requiring hospitalization.
Read MorePosted by Andy Lundin | Feb 3, 2023 | Covid 19 |
Immunexpress detailed a study that validated the use of its SeptiCyte RAPID as a triaging tool for COVID patients requiring hospitalization.
Read MorePosted by Chris Wolski | Dec 21, 2022 | Covid 19 |
Findings have revealed an underlying genetic cause for why some children who have had COVID-19 infection develop MIS-C.
Read MorePosted by Andy Lundin | Nov 24, 2022 | Melanoma |
Researchers found potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to cause progression of melanoma cells.
Read MorePosted by Andy Lundin | Nov 8, 2022 | Tuberculosis |
Pioneering artificial intelligence (AI) which automatically diagnoses lung diseases could ease winter pressures on hospitals.
Read MorePosted by Chris Wolski | Oct 3, 2022 | Company News |
Roche has announced that Matt Sause will become CEO of Roche Diagnostics and a member of the Corporate Executive Committee on January 1, 2023.
Read More